Overview
OHR designs and manufactures critical chemicals using Creationary Chemistry, starting from simple, abundant feedstocks rather than crude oil, with modular, local production. It combines engineered enzymes with primordial chemistry in a cell-free system to build carbon chains with high selectivity, creating privileged intermediates that become end products without living cells or toxic waste. This approach eliminates traditional extraction, separation, and refining steps and uses a single platform to access energetics, propellants, binders, and advanced materials across defense, mining, and propulsion. The goal is industrial sovereignty and independence, enabling distributed production near local feedstocks under a build-own-operate model to bypass concentrated supply chains.
Work here?Claim your company
Simplify's take
What believers are saying
- Ohr says it raised $75 million and reports early revenue in October 2026.
- Its job posts claim an already qualified domestic ignition source, validating commercialization beyond R&D.
- U.S. and allied defense partnerships fit the sovereignty narrative, especially amid adversary-supply dependence.
What critics are saying
- Ohr still has only 30 employees, so scaling from lab to plant remains fragile.
- The company’s own hiring notes target roughly 50 Colorado hires by mid-2027, stretching execution.
- Defense, mining, and propulsion customers demand qualification cycles; one failed plant or test kills momentum.
What makes Ohr unique
- Ohr’s October 2026 jobs describe four chemistries spanning energetics, propellants, binders, and extractants.
- It combines engineered enzymes with cell-free manufacturing, targeting selective chemistry without refining or toxic waste.
- Ohr pairs chemistry with acquisitions, buying licensed plants and embedding new molecules into existing lines.
Help us improve and share your feedback! Did you find this helpful?